Inspire Medical Reports Preliminary Q4 Results; Issues 2025 Revenue Guidance

(RTTNews) - Inspire Medical Systems (INSP) said its revenue for the fourth quarter of 2024 is anticipated to be in the range of $239.5 million to $239.7million, an approximately 25% increase over the same quarter of 2023. Revenue for full year 2024 is anticipated to be in the range of $802.6 million to $802.8million, an approximately 28% increase over 2023.

The company expects revenue for full year 2025 to be in the range of $940 million to $955 million, a 17% to 19% increase over full year 2024.

The company announced the appointment of Jason Kelly as Chief Manufacturing and Quality Officer effective January 20, 2025. Carlton Weatherby will step into the expanded role of Chief Strategy and Growth Officer and lead the U.S. Sales, Marketing, and Strategy teams. Randy Ban will transition from the role of Chief Commercial Officer to a newly created role of EVP, Patient Access and Therapy Development. Ivan Lubogo will transition from the role of SVP U.S. Sales to the newly created role of SVP, Strategic Sales. Joe Sander will be promoted to the role of SVP U.S. Sales.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.